Archived - Association Of Ezetrol® (ezetimibe) With Myalgia, Rhabdomyolysis, Hepatitis, Pancreatitis, And Thrombocytopenia -merck Frosst/schering Pharmaceuticals

Recall Summary Ezetrol (ezetimibe), a cholesterol-lowering medication distributed by Merck Frosst and Schering Pharmaceuticals, has been associated with muscle pain, muscle breakdown, liver inflammation, pancreas inflammation, and low blood platelet counts in some patients. This alert affects all Canadian users of this drug. Healthcare providers and patients were notified of these potential serious side effects.

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2005-02-01

Status

Closed

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/d851ad74-45e0-4ce1-bccf-e3f399c2fcd0